RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CAR T-Cell therapy shows promise for tough blood cancers in japanese patients
Disease control OngoingThis study tests a treatment called KTE-X19, a type of CAR T-cell therapy, in 25 Japanese adults whose mantle cell lymphoma or B-cell acute lymphoblastic leukemia has come back or not responded to other treatments. The goal is to see how well it shrinks or eliminates the cancer a…
Matched conditions: RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated May 26, 2026 10:05 UTC
-
New hope for kids with returning leukemia: blinatumomab trial underway
Disease control OngoingThis study tests a drug called blinatumomab in Chinese children (ages 1 month to 18 years) whose B-cell acute lymphoblastic leukemia has come back or not responded to standard treatment. The goal is to see if the drug can bring about a complete remission. The trial involves 18 pa…
Matched conditions: RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 10:04 UTC